Abstract:Background: Knowledge of the pattern of regression and distribution of residual tumor cells may assist in the selection of candidates for rectum-sparing strategies. Objective: To investigate and identify factors associated with tumor regression pattern and distribution of residual tumor cells. Methods: We conducted a prospective study of patients with T3/T4 N0/N+ adenocarcinoma of the middle and lower third of the rectum (≤10 cm) treated with radiotherapy (5×5 Gy) followed by 6 cycles of CAPOX chemotherapy. The pattern of tumor regression was classified as fragmented or solid. Microscopic intramural spread was measured. We used a model of distribution of residual tumor cells not yet applied to rectal cancer, defined as follows: type I (luminal), type II (invasive front), type III (concentric), and type IV (random). Results: Forty patients were included with a median age of 66 years; 23 (57.5%) were men. A fragmented pattern was identified in 18 patients (45.0%), and a solid pattern in 22 (55.0%). Microscopic intramural spread was identified in 25 patients (62.5%), extending from 1 to 18 mm (median, 4 mm). There were 14 cases (35.0%) of microscopic intramural spread ≥10 mm. All cases of fragmented regression pattern, except one, showed microscopic intramural spread. Within the fragmented pattern, microscopic intramural spread was 4–8 mm in 4 cases and ≥10 mm in the remaining cases. All cases of microscopic intramural spread ≥ 10 mm were within the fragmented pattern. Regarding the distribution pattern of residual tumor cells, 11 cases (31.5%) were classified as type I, 14 (40.0%) as type II, 10 (28.5%) as type III, and none as type IV. Carcinoembryonic antigen levels >5 ng/mL, downsizing 20 mm, and anatomopathologic lymph node involvement were significantly associated with the occurrence of fragmentation ( P <0.05). Having received all 6 cycles of CAPOX chemotherapy and absence of microscopic intramural spread were significantly associated with the type I distribution pattern ( P <0.05). Conclusion: The occurrence of a fragmented regression pattern is common, as is the presence of microscopic intramural spread. We could identify radiologic and clinicopathologic factors associated with the pattern of tumor regression and a type I distribution pattern.

Expression of Types I and III Collagens and Ultrastructure of the Extracellular Matrix in Rectal Adenocarcinoma of Different Differentiation Degree after Neoadjuvant Radiation Therapy

[Detection and Clinical Significance of Apoptosis Related Protein in Local Advanced Rectal Cancer Patients with Preoperative Neoadjuvant Therapy].

Prognostic Value of Immune Cells Subsets Within the Tumor Microenvironment in Patients With Rectal Adenocarcinoma

Comparison of Immune Microenvironment Between Different Neoadjuvant Radiotherapy Regimens for Rectal Cancer.

Exploring extracellular matrix and prostaglandin pathway alterations across varying resection margin distances of right-sided colonic adenocarcinoma

Role of Adjuvant Chemotherapy After Curative Resection in Stage II and III Rectal Cancer

Evaluation of histopathological response to neoadjuvant therapy in rectal cancer using slide‐free, stain‐free multimodal multiphoton microscopy

Identification of radiologic and clinicopathologic variables associated with tumor regression pattern and distribution of cancer cells after short-course radiotherapy and consolidation chemotherapy in patients with rectal cancer

Alteration and prognostic values of collagen gene expression in patients with gastric cancer under different treatments

Impact Of Neoadjuvant And Adjuvant Radiotherapy On Disease-Specific Survival In Patients With Stages Ii-Iv Rectal Cancer

Prognostic Value of Immunohistochemical Markers for Locally Advanced Rectal Cancer

Restaging magnetic resonance imaging of the rectum after neoadjuvant therapy: a practical guide

Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients

Content and tissue expression of Collagen I, Collagen IV, and Laminin in the Extracellular Matrix in Prostate Adenocarcinoma

Oncologic Outcomes of Primary and Post-Irradiated Early Stage Rectal Cancer: a Retrospective Cohort Study.

Advances in Clinical Investigation of Adjuvant Radiotherapy in Rectal Cancer

Effects of neoadjuvant chemotherapy with or without intensity‐modulated radiotherapy for patients with rectal cancer

The Influence of Neoadjuvant Therapy for the Prognosis in Patients with Rectal Carcinoma: a Retrospective Study

Association of stromal type IV collagen and prognosis in neoadjuvant chemotherapy-treated pancreatic cancer

IFN-Type-I Response and Systemic Immunity in Rectal Adenocarcinoma Patients Treated with Conventional or Hypofractionated Neoadjuvant Radiotherapy

Image analysis Uncovers associations between immune landscape, collagen structure, and neoadjuvant chemotherapy in high-grade serous ovarian carcinomas